What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors

Cancer Statistics, 2021

(2021) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ARID1A and CTNNB1/β-Catenin Molecular Status Affects the Clinicopathologic Features and Prognosis of Endometrial Carcinoma: Implications for an Improved Surrogate Molecular Classification

(2021) Antonio De Leo et al.   Cancers

Immunohistochemical Biomarkers as a Surrogate of Molecular Analysis in Ovarian Carcinomas: A Review of the Literature

(2021) Giacomo Santandrea et al.   Diagnostics

An integrated molecular profile of endometrioid ovarian cancer

(2020) William E. Pierson et al.   GYNECOLOGIC ONCOLOGY

The Origin of Ovarian Cancer Species and Precancerous Landscape

(2020) Ie-Ming Shih et al.   AMERICAN JOURNAL OF PATHOLOGY

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer

(2020) R.E. Miller et al.   ANNALS OF ONCOLOGY

Clear cell carcinoma of the ovary: a clinical and molecular perspective

(2020) Yasushi Iida et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach

(2020) Giulia Dondi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Genomic analysis of low‐grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities

(2020) Dane Cheasley et al.   JOURNAL OF PATHOLOGY

Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

(2020) Robert L. Hollis et al.   Nature Communications

Molecular profiling and molecular classification of endometrioid ovarian carcinomas

(2019) Paulina Cybulska et al.   GYNECOLOGIC ONCOLOGY

The molecular origin and taxonomy of mucinous ovarian carcinoma

(2019) Dane Cheasley et al.   Nature Communications

Morphology and tumor-infiltrating lymphocytes in high-stage, high-grade serous ovarian carcinoma correlated with long-term survival

(2018) Silvia Darb-Esfahani et al.   HISTOPATHOLOGY

Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics

(2018) Jaime Prat et al.   HUMAN PATHOLOGY

Disease Distribution in Low-stage Tubo-ovarian High-grade Serous Carcinoma (HGSC)

(2018) Naveena Singh et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Endometriosis-associated ovarian neoplasia

(2018) Xavier Matias-Guiu et al.   PATHOLOGY

Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas

(2018) Thing Rinda Soong et al.   JOURNAL OF PATHOLOGY

Pathology of cancers of the female genital tract including molecular pathology

(2018) Jaime Prat et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Sectioning and extensively examining the fimbriated end (SEE-FIM) of the fallopian tube in routine practices, is it worth the effort?

(2018) Natthawadee Laokulrath et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Genomic landscape and evolutionary trajectories of ovarian cancer early precursor lesions

(2018) Ren-Chin Wu et al.   JOURNAL OF PATHOLOGY

Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups

(2017) Carlos Parra-Herran et al.   MODERN PATHOLOGY

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma

(2017) Jennifer Ducie et al.   Nature Communications

Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression

(2017) Brooke E. Howitt et al.   OncoImmunology

Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes

(2016) Yaser R. Hussein et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Low-grade Serous Carcinoma of the Ovary

(2016) Geunghwan Ahn et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Long-term survival of patients with mismatch repair protein-deficient, high-stage ovarian clear cell carcinoma

(2016) Colin J R Stewart et al.   HISTOPATHOLOGY

Secretory cell outgrowths, p53 signatures, and serous tubal intraepithelial carcinoma in the fallopian tubes of patients with sporadic pelvic serous carcinoma

(2016) Radhika Srinivasan et al.   Indian Journal of Pathology and Microbiology

Letter to the Editor on “Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?” Int J Gynecol Cancer 2015;25

(2016) Jaime Prat et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Evidence for a Dualistic Model of High-grade Serous Carcinoma

(2015) Brooke E. Howitt et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

(2015) Robertson Mackenzie et al.   BMC CANCER

Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum

(2015) Naveena Singh et al.   HISTOPATHOLOGY

Whole–genome characterization of chemoresistant ovarian cancer

(2015) Ann-Marie Patch et al.   NATURE

Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum

(2015) Jaime Prat   OBSTETRICS AND GYNECOLOGY

Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

(2015) Ronald L. Chandler et al.   Nature Communications

The Histomorphology of Lynch Syndrome–associated Ovarian Carcinomas

(2014) Michael Herman Chui et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Early Detection of High-grade Tubal Serous Carcinoma in Women at Low Risk for Hereditary Breast and Ovarian Cancer Syndrome by Systematic Examination of Fallopian Tubes Incidentally Removed During Benign Surgery

(2014) Joseph T. Rabban et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development

(2014) Cheryl A Sherman-Baust et al.   JOURNAL OF PATHOLOGY

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

(2014) Gottfried E. Konecny et al.   JNCI-Journal of the National Cancer Institute

Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis

(2014) Bin Guan et al.   JNCI-Journal of the National Cancer Institute

BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management

(2014) Giulia Girolimetti et al.   Biomed Research International

Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

(2013) Kathryn P. Pennington et al.   CLINICAL CANCER RESEARCH

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy

(2013) Ren-Chin Wu et al.   JOURNAL OF PATHOLOGY

Hereditary gynaecological malignancies: advances in screening and treatment

(2012) Ann K Folkins et al.   HISTOPATHOLOGY

Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomas

(2012) Michael S Anglesio et al.   JOURNAL OF PATHOLOGY

PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma

(2011) Sohei Yamamoto et al.   JOURNAL OF PATHOLOGY

Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma

(2011) Robert A Soslow et al.   MODERN PATHOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

(2010) Robert J. Kurman et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube

(2010) Eleanor Y Chen et al.   JOURNAL OF PATHOLOGY

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY

Anaplastic Carcinoma in Mucinous Ovarian Tumors

(2009) Claudia Provenza et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary

(2009) Emanuela Veras et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Histologic Subtypes of Ovarian Carcinoma

(2009) Robert A. Soslow   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Serous Carcinogenesis in the Fallopian Tube

(2009) Elke Jarboe et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Pathogenesis of Ovarian Cancer

(2009) Robert J. Kurman et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations

(2008) Ann K. Folkins et al.   GYNECOLOGIC ONCOLOGY